Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Belgium, Brazil +16 more
Sponsor: Odense University Hospital
Neurogenic Dysfunction of the Urinary Bladder · Multiple Sclerosis · Sacral Neuromodulation · Bowel Dysfunction
Denmark
- Effects of Sensorimotor Insoles on Stability and Gait in Patients With Multiple Sclerosis.Active Not Recruiting
Sponsor: University of Salamanca
Multiple Sclerosis
Spain
Sponsor: Universidad de Almeria
Multiple Sclerosis (MS) - Relapsing-remitting
Spain
Sponsor: Tongji Hospital
Autoimmune Diseases of the Nervous System · Neuromyelitis Optica Spectrum Disorder · Multiple Sclerosis · Guillain-Barre Syndrome
China
Sponsor: University of Maryland, Baltimore
Multiple Sclerosis (MS) - Relapsing-remitting
United States
- A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Austria, Belarus +32 more
Sponsor: Novartis Pharmaceuticals
Secondary Progressive Multiple Sclerosis (SPMS)
United States, Argentina, Australia, Austria, Belgium +27 more
Sponsor: Sonia Batista
Multiple Sclerosis
Portugal
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis · Progressive Multifocal Leukoencephalopathy
United States
- Physical Activity Intervention for Individuals Newly Diagnosed With MSNot Yet Recruiting
Sponsor: University of Illinois at Chicago
Multiple Sclerosis
United States
Sponsor: Hasselt University
Multiple Sclerosis
Belgium
Sponsor: AstraZeneca
Systemic Sclerosis · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Australia, Germany, Spain, Sweden +1 more
Sponsor: Gregory Wu
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Neurodevelopmental Disorders · Autism · Autism Spectrum Disorder · Fragile X Syndrome
Canada
- Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)Active Not Recruiting
Sponsor: Amgen
Relapsing-remitting Multiple Sclerosis (RRMS)
United States, Belgium, Bulgaria, Canada, Croatia +17 more
Sponsor: Sanko University
Multiple Sclerosis · Dysphagia · Deglutition Disorders
Turkey (Türkiye)
Sponsor: University of Washington
Multiple Sclerosis
United States
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Bulgaria +17 more
Sponsor: University of Vigo
Multiple Sclerosis · Exercise (EX) · Physical Therapy · Virtual Reality Exposure Therapy
Spain
Sponsor: University of California, Los Angeles
Tuberous Sclerosis Complex
United States
Sponsor: PhenoNet, Inc.
Amyotrophic Lateral Sclerosis (ALS)
United States, Czechia, Germany, Poland, Serbia +1 more
- A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis (PMS)
United States, Bosnia and Herzegovina, Brazil, Canada, Colombia +19 more
- Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory StudyNot Yet Recruiting
Sponsor: University of Washington
Multiple Sclerosis
United States
Sponsor: Gaziantep Islam Science and Technology University
Neurogenic Bladder Disorder · Spinal Cord Injury · Multiple Sclerosis · Lower Urinary Track Symptoms
Turkey (Türkiye)